Chlamydia trachomatis persistence in vitro: An overview

Journal of Infectious Diseases

Volumn 201, Issue SUPPL. 2, 2010, Pages

  Wyrick, Priscilla B ^a  

^a East Tennessee State University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; AZITHROMYCIN; GAMMA INTERFERON; IRON; PENICILLIN G; ANTIINFECTIVE AGENT;

BACTERIAL GROWTH; BACTERIAL METABOLISM; CELL DIFFERENTIATION; CHLAMYDIA TRACHOMATIS; GONOCOCCAL URETHRITIS; HERPES SIMPLEX; IN VITRO STUDY; IN VIVO STUDY; IRON DEFICIENCY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN MALNUTRITION; REVIEW; UTERINE CERVICITIS; ARTICLE; CHLAMYDIASIS; CYTOLOGY; DRUG EFFECT; ENDOMETRIUM; EPITHELIUM CELL; FEMALE; GROWTH, DEVELOPMENT AND AGING; HUMAN; MICROBIOLOGY; PATHOGENICITY; PHYSIOLOGY;

ANTI-BACTERIAL AGENTS; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; ENDOMETRIUM; EPITHELIAL CELLS; FEMALE; HUMANS; PHENOTYPE;

EID: 77953106691     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/652394     Document Type: Review

References (44)

1. Abdel Rahman YM, Belland RJ. The chlamydial developmental cycle. FEMS Microbiol Rev 2005; 29:949-959.
2. Belland RJ, Zhong G, Crane DD, et al. Genomic transcriptional profiling of the developmental cycle of Chlamydia trachomatis. Proc Natl Acad Sci U S A 2003; 100:8478-8483.
3. Rank RG, Whittimore J, Bowlin AK, Dessus-Babus S, Wyrick PB. Chlamydiae and polymorphonuclear leukocytes: unlikely allies in the spread of chlamydial infection. FEMS Immunol Med Microbiol 2008; 54: 104-113.
4. Holmes KK, Johnson DW, Floyd TM, Kvale PA. Studies of venereal disease. II. Observation on the incidence, etiology and treatment of the post-gonococcal urethritis syndrome. JAMA 1967; 202:467-473.
5. Richmond SJ, Hilton AL, Clarke SK. Chlamydial infection: role of Chlamydia subgroup A in non-gonococcal and post-gonococcal urethritis. Br J Vener Dis 1972; 48:437-444.
6. Matsumoto A, Manire GP. Electron microscopic observations on the effect of penicillin on the morphology of Chlamydia psittaci. J Bacteriol 1970; 101:278-285.
7. Nicholson T, Stephens RS. Chlamydial genomic transcriptional profile for penicillin-induced persistence. In: Schachter J, Christiansen G, Clarke IN, et al., eds. Chlamydial infections. Proceedings of the Tenth International Symposium on Human Chlamydial Infections. San Francisco, CA: International Chlamydia Symposium, 2002:611-614.
8. Galasso GJ, Manire GP. Effect of antiserum and antibiotics on persistent Infection of HeLa cells with meningpneumonitis virus. J Immunol 1961; 86:382-385.
9. Beatty WL, Morrison RP, Byrne GI. Persistent chlamydiae: from cell culture to a paradigm for chlamydial pathogenesis. Microbiol Rev 1994; 58:686-699. (Pubitemid 124005209)
10. Hogan, RJ, Mathews SA, Mukhopadhyay S, Summersgill JT, Timms P.Chlamydial persistence: beyond the basic paradigm. Infect Immun 2004; 72:1843-1855.
11. Hanna L, Merigan TC, Jawetz E. Inhibition of TRIC agents by virus induced interferon. Proc Soc Exp Biol Med 1966; 122:417-421.
12. Kazar J, Gillmore JD, Gordon FB. Effect of interferon and interferon inducers on infection with a non-viral intracellular microorganism,Chlamydia trachomatis. Infect Immun 1971; 3:825-832.
13. Byrne G I, Lehmann LK, Landry GJ. Induction of tryptophan catabolism is the mechanism for gamma-interferon-mediated inhibition of intracellular Chlamydia psittaci replication in T24 cells. Infect Immun 1986; 53:347-351.
14. Caldwell H D, Wood H, Crane D, et al. Polymorphisms in Chlamydia trachomatis tryptophan synthase genes differentiate between genital and ocular isolates. J Clin Investig 2003; 111:1757-1769.
15. Beatty WL, Byrne GI, Morrison RP. Morphological and antigenic characterization of interferon-γ mediated persistent Chlamydia trachomatis infection in vitro. Proc Natl Acad Sci U S A 1993; 90:3998-4002.
16. Brunham, RC, Peeling RW. C. trachomatis antigens: role in immunity and pathogenesis. Infect Agents Dis 1994; 3:218-333.
17. Rasmussen SJ, Timms P, Beatty PR, Stephens RS. Cytotoxic-T-lymphocyte- mediated cytolysis of L cells persistently infected with Chlamydia spp. Infect Immun 1996; 64:1944-1949. (Pubitemid 26165650)
18. Moulder J. Inhibition of onset of overt multiplication of Chlamydia psittaci in persistently infected mouse fibroblasts (L cells). Infect Immun 1983; 39:898-907.
19. Coles AM, Reynolds DJ, Harper A, Devitt A, Pearce JH. Low-nutrient induction of abnormal chlamydial development: a novel component of chlamydial pathogenesis? FEMS Microbiol Lett 1993; 106:193-200.
20. Raulston JE. Response of Chlamydia trachomatis serovar E to iron restriction in vitro and evidence for iron-regulated chlamydial proteins. Infect Immun 1997; 65:4539-4547.
21. Division of STD Prevention, Centers for Disease Control and Prevention. Sexually transmitted disease surveillance, 1996. Atlanta, GA: Centers for Disease Control and Prevention, 1997.
22. Rothermel CD, Rubin BY, Jaffe EA, Murray HW. Oxygen-independent inhibition of intracellular Chlamydia psittaci growth by human monocytes and interferon-γ-activated macrophages. J Immunol 1986; 137: 689-692.
23. Koehler L, Nettelnbreker E, Hudson AP, et al. Ultrastructural and molecular analyses of the persistence of Chlamydia trachomatis (serovar K) in human monocytes. Microb Pathog 1997; 22:133-142.
24. Gérard HC, Krausse-Opatz B, Wang Z, et al. Expression of Chlamydia trachomatis genes encoding products required for DNA synthesis and cell division during active versus persistent infection. Mol Microbiol 2001; 41:731-741.
25. Richmond S. Division and transmission of inclusions inChlamydia trachomatis in replicating McCoy cell monolayers. FEMS Microbiol Letters 1985; 29:49-52.
26. Guseva NV, Knight ST, Whittimore JD, Wyrick PB. Primary cultures of female swine genital epithelial cells in vitro: a new approach for the study of hormonal modulation of Chlamydia infection. Infect Immun 2003; 71:4700-4710.
27. Deka S, Vanover J, Dessus-Babus S et al. C. trachomatis enters a viable but non-cultivable (persistent) state within herpes simplex virus type 2 (HSV-2) co-infected cells. Cell Microbiol 2006; 8:149-162.
28. Deka S, Vanover J, Sun J, Kintner J, Whittimore J, Schoborg RV. An early event in the herpes simplex virus type-2 replication cycle is suf ficient to induce Chlamydia trachomatis persistence. Cell Microbiol 2006; 9:725-737.
29. Ouellette SP, Hatch TP, AbdelRahman YM, Rose LA, Belland RJ, Byrne GI.Global transcriptional up-regulation in the absence of increased translation in Chlamydia during IFNg-mediated host cell tryptophan starvation. Mol Microbiol 2006; 62:1387-1401.
30. Maurer AP, Mehlitz A, Mollenkopf HJ, Meyer TF. Gene expression profiles of Chlamydophila pneumoniae during the developmental cycle and iron depletion-mediated persistence. PLoS Pathog 2007; 3:e83.
31. Goellner S, Schubert E, Liebler-Tenorio E, Hotzel H, Saluz HP, Sachse K. Transcriptional response patterns of Chlamydophila psittaci in different in vitro models of persistent infection. Infect Immun 2006; 74: 4801-4808.
32. Mathews S, George C, Flegg C, Stenzel D, Timms P. Differential expression of ompA, ompB, pyk, nlpD and Cpn0585 genes between normal and interferon-gamma treated cultures of Chlamydia pneumoniae. Microb Pathog 2001; 30:337-435. (Pubitemid 32613452)
33. Gerard H, Whittum-Hudson J, Schumacher HR, Hudson A. Differential expression of three C. trachomatis hsp-60-encoding genes in active vs. persistent infections. Microb Pathog 2004; 36(1):35-39.
34. LaRue RW, Dill BD, Giles DK, Whittimore JD, Raulston JE. Chlamydial HSP60-2 is iron responsive in C. trachomatis serovar E-infected human endometrial epithelial cells. Infect Immun 2007; 75:2374-2380.
35. Workowski KA, Lampe MF, Wong KG, Watts MB, Stamm WE. Longterm eradication of Chlamydia trachomatis genital infection after antimicrobial therapy: evidence against persistent infection. JAMA 1993; 270:2071-2075.
36. Ficarra M, Ibana JSA, Poretta C, et al. A distinct cellular profile is seen in the human endocervix during Chlamydia trachomatis infection. Am J Reprod Immunol 2008; 60(5):415-425.
37. Lamb E. Top 200 prescription drugs of 2006. Pharmacy Times, 1 May 2007. http://www.pharmacytimes.com/issue/pharmacy/2007/2007-05/2007-05-6472. Accessed 22 April 2010.
38. Wyrick PB, Knight ST. Pre-exposure of infected human endometrial epithelial cells to penicillin in vitro renders Chlamydia trachomatis refractory to azithromycin. J Antimicrob Chemother 2004; 54:79-85.
39. Gieffers J, Fullgraf H, Jahn J, et al. Chlamydia pneumoniae infection in circulating human monocytes is refractory to antibiotic treatment. Circulation 2001; 103:351-356.
40. Rank RG, Sanders MM, Kidd, AT. Influence of the estrus cycle of the development of upper genital tract pathology as a result of chlamydial infection in the guinea pig model of pelvic inflammatory disease. Am J Pathol 1993; 142:1291-1296.
41. Pasley JN, Rank RG, Hough AJ Jr, Cohen A, Barron AL. Effects of various doses of estradiol on chlamydial genital infection in ovarectomized guinea pigs. Sex Transm Dis 1985; 12:8-13. (Pubitemid 15143203)
42. Sweet RL, Landers DV, Walker C, Schachter J. C. trachomatis infection and pregnancy outcome. Am J Obstet Gynecol 1987; 156:824-829.
43. Darville T, Hiltke TJ. Pathogenesis of genital tract disease due to Chlamydia trachomatis. J Infect Dis 2010; 201 (suppl 2):S114-S125 (in this supplement).
44. Rank RG, Whittum-Hudson JA. Protective immunity to chlamydial genital infection: evidence from animal studies. J Infect Dis 2010; 201(suppl 2):S168-S177 (in this supplement).